Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3487)
All Articles published online
|
Jun 7, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan KK, Guirgis M, Dinh T, George J, Dev A, Lee A, Zekry A. Treatment responses in Asians and Caucasians with chronic hepatitis C infection. World J Gastroenterol 2008; 14(21): 3416-3420 [PMID: 18528940 DOI: 10.3748/wjg.14.3416] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3416.htm |
| Number | Citing Articles |
| 1 |
N. H. Nguyen, P. VuTien, R. T. Garcia, H. Trinh, H. Nguyen, K. Nguyen, B. Levitt, M. H. Nguyen. Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6. Journal of Viral Hepatitis 2010; 17(10): 691 doi: 10.1111/j.1365-2893.2009.01226.x
|
| 2 |
Giuseppe Indolfi, Giusi Mangone, Elisa Bartolini, Gabriella Nebbia, Pier Luigi Calvo, Maria Moriondo, Pier-Angelo Tovo, Maurizio de Martino, Chiara Azzari, Massimo Resti, David R. Booth. Comparative Analysis of rs12979860 SNP of the IFNL3 Gene in Children with Hepatitis C and Ethnic Matched Controls Using 1000 Genomes Project Data. PLoS ONE 2014; 9(1): e85899 doi: 10.1371/journal.pone.0085899
|
| 3 |
Xiang-Wei Liao, Yun Ling, Xin-Hua Li, Yue Han, Shen-Ying Zhang, Lei-Lei Gu, De-Ming Yu, Bi-Lian Yao, Dong-Hua Zhang, Gen-Di Jin, Zhi-Meng Lu, Qi-Ming Gong, Xin-Xin Zhang. Association of Genetic Variation in Il28B with Hepatitis C Treatment-Induced Viral Clearance in the Chinese Han Population. Antiviral Therapy 2011; 16(2): 141 doi: 10.3851/IMP1703
|
| 4 |
Gautam Ray. Factors affecting outcome of treatment of chronic hepatitis C: result of an open label study from eastern India. Tropical Doctor 2016; 46(1): 28 doi: 10.1177/0049475515569519
|
| 5 |
Muhammad Imran, Sobia Manzoor, Sikandar Azam, Saleha Resham. Genetic variant of IL28B rs12979860, as predictive marker of interferon‐based therapy in Pakistani population. APMIS 2015; 123(4): 342 doi: 10.1111/apm.12365
|
| 6 |
K. Muller, A. Rodgers, R. Wundke, V. Waddell, R. Altus, D. L. Gordon, A. Wigg. Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward. Internal Medicine Journal 2012; 42(7): 765 doi: 10.1111/j.1445-5994.2012.02798.x
|
| 7 |
Philip Vutien, Nghia H Nguyen, Huy N Trinh, Jiayi Li, Ruel T Garcia, Gabriel Garcia, Khanh K Nguyen, Huy A Nguyen, Brian S Levitt, Emmet B Keeffe, Mindie H Nguyen. Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C. American Journal of Gastroenterology 2010; 105(5): 1110 doi: 10.1038/ajg.2009.635
|
| 8 |
Huy Anh Tran, Glenn Edward Malcolm Reeves, Robert Gibson, John Richard Attia. Development of thyroid diseases in the treatment of chronic hepatitis C with α‐interferon may be a good prognosticator in achieving a sustained virological response: A meta‐analysis. Journal of Gastroenterology and Hepatology 2009; 24(7): 1163 doi: 10.1111/j.1440-1746.2009.05874.x
|
| 9 |
Jacinta A Holmes, William Sievert, Alexander J Thompson.
IL28B
Polymorphism and Genetic Biomarkers of Viral Clearance in Hepatitis C Virus Infection
. Biomarkers in Medicine 2011; 5(4): 461 doi: 10.2217/bmm.11.47
|
| 10 |
Kenneth Kar-Lung Yan, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan. Rate and Factors Affecting Treatment Uptake of Patients with Chronic Hepatitis C in a Tertiary Referral Hospital. Digestive Diseases and Sciences 2010; 55(12): 3541 doi: 10.1007/s10620-010-1412-1
|
| 11 |
Huy A Tran, Tracey L Jones, Robert Gibson, Glenn EM Reeves. Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study. BMC Endocrine Disorders 2011; 11(1) doi: 10.1186/1472-6823-11-10
|
| 12 |
Siddapuram Sivaprasad, Padaki Nagaraja Rao, Rajesh Gupta, Kaitha Ashwini, Duvvuru Nageshwar Reddy. The Distribution of Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra Pradesh, India. Journal of Clinical and Experimental Hepatology 2012; 2(2): 112 doi: 10.1016/S0973-6883(12)60098-X
|
| 13 |
Hu Li, Jia-Li Tan, Jian-Rui Li, Nan-Nan Liu, Jin-Hua Chen, Xiao-Qin Lv, Li-li Zou, Biao Dong, Zong-Gen Peng, Jian-Dong Jiang. A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. Biomedicine & Pharmacotherapy 2019; 116: 108976 doi: 10.1016/j.biopha.2019.108976
|
| 14 |
Deepinder Kaur, Rajoo Singh Chhina, Omesh Goyal, Prerna Goyal. Treatment results and factors affecting sustained virological response in chronic hepatitis C patients in Northern India. Journal of Gastrointestinal Infections 2015; 5(1): 24 doi: 10.5005/jp-jogi-5-1-24
|
| 15 |
Alip Ghosh, Sara Romani, Shyam Kottilil, Bhawna Poonia. Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal. International Journal of Molecular Sciences 2020; 21(20): 7473 doi: 10.3390/ijms21207473
|
| 16 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the Treatment of HIV-/HCV-Coinfected Patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
| 17 |
Christine Y. Chang, Pauline Nguyen, An Le, Changqing Zhao, Aijaz Ahmed, Tami Daugherty, Gabriel Garcia, Glen Lutchman, Radhika Kumari, Mindie H. Nguyen. Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease. Medicine 2017; 96(6): e6128 doi: 10.1097/MD.0000000000006128
|
| 18 |
Thomas Urban, Michael R. Charlton, David B. Goldstein. Introduction to the genetics and biology of interleukin-28B. Hepatology 2012; 56(1): 361 doi: 10.1002/hep.25794
|
| 19 |
Albert Friedrich Stättermayer, Rudolf Stauber, Harald Hofer, Karoline Rutter, Sandra Beinhardt, Thomas Matthias Scherzer, Kerstin Zinober, Christian Datz, Andreas Maieron, Emina Dulic–Lakovic, Harald H. Kessler, Petra Steindl–Munda, Michael Strasser, Christoph Krall, Peter Ferenci. Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology 2011; 9(4): 344 doi: 10.1016/j.cgh.2010.07.019
|
| 20 |
Sabela Lens García, Mairene Coto-Llerena, Sofía Pérez del Pulgar Gallart, Xavier Forns Bernhardt. Genética y tratamiento de la hepatitis C: ¿hacia un tratamiento personalizado?. Gastroenterología y Hepatología 2011; 34(5): 352 doi: 10.1016/j.gastrohep.2010.12.008
|
| 21 |
Paul J Clark, Alex J Thompson, John G McHutchison. IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies. American Journal of Gastroenterology 2011; 106(1): 38 doi: 10.1038/ajg.2010.370
|
| 22 |
Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh. High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice. Clinical and Molecular Hepatology 2013; 19(1): 60 doi: 10.3350/cmh.2013.19.1.60
|
| 23 |
Kasem Kulkeaw, Worakamol Pengsart. Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases. Micromachines 2021; 12(7): 842 doi: 10.3390/mi12070842
|
| 24 |
Arghavan Haj-sheykholeslami, Maryam Keshvari, Heidar Sharafi, Ali Pouryasin, Khalil Hemmati, Fatemeh Mohammadzadehparjikolaei. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. World Journal of Gastroenterology 2015; 21(29): 8935-8942 doi: 10.3748/wjg.v21.i29.8935
|
| 25 |
Mahtab Daneshvar, Mehri Nikbin, Solmaz Talebi, Foozieh Javadi, Mohammad Reza Aghasadeghi, Sanaz Mahmazi, Seyed Mehdi Sadat. Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C. Iranian Red Crescent Medical Journal 2016; 18(9) doi: 10.5812/ircmj.28566
|
| 26 |
L. H. Nguyen, M. H. Nguyen. Systematic review: Asian patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics 2013; 37(10): 921 doi: 10.1111/apt.12300
|
| 27 |
BYM Soh, R Kumar, VSM Ekstrom, CYH Lin, S Thangaraju, HH Tan, KP Chan, LHL Choong, D Teo, WC Chow. Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations. Singapore Medical Journal 2019; 60(1): 34 doi: 10.11622/smedj.2018078
|
| 28 |
Dongliang Ge, Jacques Fellay, Alexander J. Thompson, Jason S. Simon, Kevin V. Shianna, Thomas J. Urban, Erin L. Heinzen, Ping Qiu, Arthur H. Bertelsen, Andrew J. Muir, Mark Sulkowski, John G. McHutchison, David B. Goldstein. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461(7262): 399 doi: 10.1038/nature08309
|
| 29 |
Dong-Won Kim, Seoung-Ae Lee, Hong Kim, You-Sub Won, Bum-Joon Kim, Jason Blackard. Naturally Occurring Mutations in the Nonstructural Region 5B of Hepatitis C Virus (HCV) from Treatment-Naïve Korean Patients Chronically Infected with HCV Genotype 1b. PLoS ONE 2014; 9(1): e87773 doi: 10.1371/journal.pone.0087773
|
| 30 |
LI-SHENG WU, HONG WANG, XIAO-PING GENG. Two IL28B polymorphisms are associated with the treatment response of different genotypes of hepatitis C in different racial populations: A meta-analysis. Experimental and Therapeutic Medicine 2012; 3(2): 200 doi: 10.3892/etm.2011.385
|
| 31 |
Ajit Sood, Vandana Midha, Omesh Goyal, Syed Hissar, Suresh Kumar Sharma, Pankaj Khanna. Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India. Indian Journal of Gastroenterology 2014; 33(4): 343 doi: 10.1007/s12664-014-0451-5
|
| 32 |
Ashwin Balagopal, David L. Thomas, Chloe L. Thio. IL28B and the Control of Hepatitis C Virus Infection. Gastroenterology 2010; 139(6): 1865 doi: 10.1053/j.gastro.2010.10.004
|
| 33 |
Lourianne N. Cavalcante, Kiyoko Abe‐Sandes, Ana Luiza D. Angelo, Taisa M. B. Machado, Denise C. Lemaire, Carlos M. C. Mendes, João R. Pinho, Fernanda Malta, Luiz G.C. Lyra, André C. Lyra. IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population. Liver International 2012; 32(3): 476 doi: 10.1111/j.1478-3231.2011.02653.x
|
| 34 |
Xiao-Xiao Wang, Bi-Fen Luo, Han-Ji Jiang, Xu Cong, Qian Jin, Dan-Li Ma, Lai Wei, Bo Feng. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir. World Journal of Gastroenterology 2018; 24(40): 4554-4564 doi: 10.3748/wjg.v24.i40.4554
|
| 35 |
Victoria A. Sublette, Mark W. Douglas, Kirsten McCaffery, Jacob George, Kathryn Nicholson Perry. Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review. Liver International 2013; 33(6): 894 doi: 10.1111/liv.12138
|
| 36 |
Wangxia Tong, Jianyun Zhu, Ning Luo, Xiaohua Yang, Zhiying Lei, Xiaoliang Huang, Zhixin Zhao, Xiaohong Zhang, Zhiliang Gao, Zhonghua Jiang. Response to Pegylated Interferon Plus Ribavirin in Patients with Hepatitis C Virus Genotype 6a Infection from Guangdong and Guangxi Province of China. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5397407
|